Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF March 25, 2016 | Archived Issues

FDA Warns About Zydelig

Pharmacy Focus

The U.S. Food and Drug Administration is alerting healthcare professionals about reports of an increased rate of adverse events, including deaths, in clinical trials with the cancer medicine Zydelig in combination with other cancer medicines.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - March 2016 (PDF)  


Milestones

Morton W. Klein, MD, has died.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Orders for L/S Ratio No Longer Sent Out

As of April 1, Pathology and Laboratory Medicine will no longer send out orders for lecithin-sphingomyelin (L/S) ratio to assess fetal lung maturity. In-house service was discontinued in August 2015 and no orders have been sent out in more than six months.

Several published reports have demonstrated that a lamellar body count of 40,000-50,000 is strongly correlated to fetal lung maturity (e.g., sensitivity greater than 90 percent). Lamellar body counts can be obtained on a 24/7 basis in-house via the Core Laboratory. Pathology and Laboratory Medicine encourages use of lamellar body counts for fetal lung maturity in lieu of L/S ratio, which is a technically difficult, laborious and dated assay that has fallen out of favor.

If you have questions, contact Kimia Sobhani, PhD, at kimia.sobhani@cshs.org or Holli Mason, MD, at holli.mason@cshs.org.